Covid Antibody

Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.

The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in

In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.

Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.

Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.

By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.

Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.

Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.

Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.

According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.

Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".

Use of antivirals or monoclonal antibodies is not recommended for those less than 18 years of age, irrespective of severity of Covid infection, the government said on Thursday.

A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.

Researchers have discovered an antibody that could counter all known variants of the coronavirus that causes COVID-19 and also distantly related ones that infect other animals.

The EG.5.1 variant of SARS-CoV-2 can escape neutralising antibodies better than other currently circulating strains, giving it an advantage in infecting vaccinated or previously infected people, according to a study published in

In this article, we discuss all the latest info about the Arcturus variant, its symptoms, and how you can prevent getting infected.

Two COVID-19 antibody treatments are no longer recommended by the World Health Organisation because Omicron and its subvariants have likely rendered them obsolete, according to a revised guideline published in the British Medical Journal.

Two new sublineages of the Omicron coronavirus variant can dodge antibodies from earlier infection well enough to trigger a new wave.

By February of this year, 58 percent of the US population -- more than 190 million people -- had been infected with Covid, according to an antibody survey by the Centers for Disease Control and Prevention (CDC) published Tuesday.

A heat-stable COVID-19 vaccine that is being developed in India and does not need cold chain storage has generated strong antibody response against coronavirus variants, including Delta and Omicron, according to a study on mice.

Neutralising antibody levels waned after six months in those who were fully vaccinated against the coronavirus with Covishield, Covaxin and a mix of both with regard to Omicron variant, a study done by the National Institute of Virology indicated.

Antibodies produced by two-doses of mRNA vaccines against the original and early variants of the SARS-CoV-2 virus wane substantially over time, and offer essentially no protection against Omicron, according to a study.

Antibodies produced by immune cells become steadily more formidable and precisely targeted against the SARS-CoV-2 virus for at least six months after COVID-19 vaccination, according to a study.

Mild- to moderate-intensity exercise for 90 minutes after getting a flu or COVID-19 vaccine may boost the levels of antibodies in the body, according to a study.

According to new research, people over age 65 at the highest risk for severe COVID-19 have often been the least likely to receive monoclonal antibodies (mAbs). -- a highly effective treatment for the disease -- both across and within US states.

Top virologist Dr Gagandeep Kang has called the prescription of monoclonal antibody therapy by the doctors in the private hospitals of the country for the treatment of Omicron variant of COVID-19 patients "unethical, immoral and unscientific".

Use of antivirals or monoclonal antibodies is not recommended for those less than 18 years of age, irrespective of severity of Covid infection, the government said on Thursday.

A third dose of COVID-19 vaccine increases the level of antibodies that can effectively neutralise the Omicron variant of coronavirus, according to a study published in The Lancet journal.